Providers must balance safety, choice with resident alcohol use … USC targeting dementia research in plans for $300M medical school … LeadingAge supports greenhouse gas reduction in affordable senior...
More news for Wednesday, Jan. 4
By
Kimberly Bonvissuto
Jan 04, 2023
$10K reward offered for info about murders of assisted living couple … SC health department takes emergency action against 4 assisted living communities … Grant provides memory care training for senior...
A memorable tree
By
Lois A. Bowers
Jan 04, 2023
Photos of residents of Vista West adorned the Christmas tree in the drawing room in the Wisconsin governor’s residence this year. Find out more, and learn how to submit your photos!
US life expectancy drops for second year thanks to COVID-19, drug overdoses: CDC
By
Kimberly Bonvissuto
Jan 03, 2023
Life expectancy in the United States fell for a second consecutive year due to COVID-19 deaths and drug overdoses, falling to the shortest lifespan since 1996, according to a recent report from the Centers...
Natural environments may cut hospitalization for patients with neurodegenerative diseases
Dec 30, 2022
The normalized difference vegetation index was negatively associated with hospitalization for Alzheimer’s disease and related dementia as well as Parkinson’s disease.
Congressional report slams FDA, drugmaker over approval of Alzheimer’s drug Aduhelm
Dec 29, 2022
The controversy over aducanumab (Aduhelm) stretches back to its June 2021 approval by the US Food and Drug Administration.
5α-reductase inhibitors linked to depression, but not dementia
Dec 29, 2022
The magnitude of association for finasteride and dutasteride with dementia decreased over time and became nonsignificant.
Senior living celebrates ‘big wins’ in proposed $1.7 trillion omnibus package
By
Kimberly Bonvissuto
Dec 21, 2022
Senior living advocates are claiming “major victories” for the industry following the release of the proposed $1.7 trillion congressional year-end spending bill on Monday.
Alzheimer’s Association asks CMS to provide full coverage of FDA-approved dementia drugs
By
Kimberly Bonvissuto
Dec 21, 2022
Every day, more than 2,000 older adults living with mild dementia may transition to a more advanced stage of the disease and no longer be eligible for lecanemab and other antibodies targeting amyloid under...
PET changes similar for Alzheimer’s disease, Down syndrome
Dec 20, 2022
“This study shows that, although there are subtle differences, Alzheimer’s disease pathophysiology is similar among people with Down syndrome and people with autosomal dominant Alzheimer’s...